WallStSmart
AGL

agilon health Inc

NYSE: AGL · HEALTHCARE · MEDICAL CARE FACILITIES

$59.61
+1.70% today

Updated 2026-06-05

Market cap
$1.54B
P/E ratio
P/S ratio
0.27x
EPS (TTM)
$-22.59
Dividend yield
52W range
$7 – $95
Volume
0.8M

agilon health Inc (AGL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2019202020212022202320242025
Revenue$794.41M$1.22B$1.52B$2.39B$4.32B$6.06B$5.93B
Revenue growth (YoY)+53.4%+24.9%+57.0%+80.7%+40.4%-2.1%
Cost of revenue$765.90M$1.12B$1.46B$2.28B$4.25B$6.06B$6.12B
Gross profit$28.51M$94.15M$65.74M$111.36M$69.67M$4.84M$-188.61M
Gross margin3.6%7.7%4.3%4.7%1.6%0.1%-3.2%
R&D
SG&A$122.83M$137.29M$427.50M$207.79M$285.76M$268.91M$238.54M
Operating income$-106.57M$-56.67M$-372.24M$-105.38M$-232.13M$-292.13M$-421.08M
Operating margin-13.4%-4.7%-24.5%-4.4%-5.4%-4.8%-7.1%
EBITDA$-64.21M$-40.11M$-362.16M$-72.41M$-167.64M$-218.19M$-368.86M
EBITDA margin-8.1%-3.3%-23.8%-3.0%-3.9%-3.6%-6.2%
EBIT$-105.62M$-54.21M$-376.83M$-86.19M$-187.80M$-242.65M$-397.45M
Interest expense$9.07M$8.13M$6.15M$4.48M$6.66M$6.18M$6.64M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-282.59M$-60.05M$-406.49M$-106.55M$-262.60M$-260.15M$-405.35M
Net income growth (YoY)+78.7%-576.9%+73.8%-146.4%+0.9%-55.8%
Profit margin-35.6%-4.9%-26.7%-4.5%-6.1%-4.3%-6.8%

Frequently asked questions

What is agilon health Inc's revenue?

agilon health Inc's trailing twelve-month revenue is $5.82B. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is AGL?

In its most recent fiscal year, AGL ran a gross margin of -3.18%, an operating margin of -7.10%, and a net margin of -6.83%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does AGL generate?

AGL produced $-119.00M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is AGL's balance sheet healthy?

AGL holds $173.71M in cash and equivalents against $15.75M in long-term debt, on $126.73M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.